申请人:LABORATOIRE BIODIM
公开号:EP2725029A1
公开(公告)日:2014-04-30
The invention relates to compounds of formula (I)
wherein,
- A1 and A2, identical or different, are H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C2-C6) alkenyl, (C2-C6) alkynyl, (C1-C6) alkyl-ORa, (C1-C6) alkyl-SRa, (C1-C6) alkyl-NRaRb, ORa, SRa, NRaRb, or CORa;
- A3 is H, OH or form a carbonyl with A4;
- A4 is H, OH or form a carbonyl with A3;
- A5 is H, OH, CRaRbOH or F;
- A6 is H or F;
- X is CH2, CHF, CF2, CHOH, O, S, NRa or a simple bond;
- Y is P(O) (ORa) (ORb) or P(O) (ORa) (NRaRb) ;
- V is O or S;
- A7 is H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C2-C6) alkenyl, (C2-C6) alkynyl or (C1-C6) alkyl-ORa;
- Ra and Rb, identical or different, are selected from the group consisting of H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C1-C6) alkyl-OH and (C1-C6) alkyl-O-(C1-C6) alkyl;
and their addition salts thereof with acids and bases, their preparation and their use in the antibacterial prevention and therapy, used alone or in association with antibacterials, antivirulence agents or drugs reinforcing the host innate immunity.
该发明涉及式(I)的化合物,其中,- A1和A2,相同或不同,为H,(C1-C6)烷基,(C1-C6)氟烷基,(C2-C6)烯基,(C2-C6)炔基,(C1-C6)烷基-ORa,(C1-C6)烷基-SRa,(C1-C6)烷基-NRaRb,ORa,SRa,NRaRb或CORa;- A3为H,OH或与A4形成羰基;- A4为H,OH或与A3形成羰基;- A5为H,OH,CRaRbOH或F;- A6为H或F;- X为CH2,CHF,CF2,CHOH,O,S,NRa或简单键;- Y为P(O)(ORa)(ORb)或P(O)(ORa)(NRaRb);- V为O或S;- A7为H,(C1-C6)烷基,(C1-C6)氟烷基,(C2-C6)烯基,(C2-C6)炔基或(C1-C6)烷基-ORa;- Ra和Rb,相同或不同,选自H,(C1-C6)烷基,(C1-C6)氟烷基,(C1-C6)烷基-OH和(C1-C6)烷基-O-(C1-C6)烷基的群;以及它们与酸和碱的加合盐,它们的制备以及它们在抗菌预防和治疗中的应用,单独使用或与抗菌剂、抗毒力剂或增强宿主固有免疫的药物联合使用。